Atopic Dermatitis

>

Latest News

Dupilumab improves atopic dermatitis severity in adolescents, adults with skin of color | Image Credit: © this_baker - © this_baker - stock.adobe.com.
Dupilumab improves atopic dermatitis severity in adolescents, adults with skin of color

June 9th 2025

Results at 24 weeks revealed that 76% of individuals achieved a 75% or more improvement in overall disease severity (EASI-75), trial's primary endpoint.

Pediatric FDA, clinical trial, and interview recap from Q1 2025 | Image Credit: © Araki Illustrations - © Araki Illustrations  - stock.adobe.com.
Q1 2025: A recap of the top headlines and interviews

April 3rd 2025

Peter Lio, MD
Peter Lio, MD, highlights recent lebrikizumab data to treat atopic dermatitis

March 27th 2025

Image Credit: © Elroi - stock.adobe.com.
Tapinarof cream 1% demonstrates positive long-term results for atopic dermatitis in patients 2 years and up

March 10th 2025

Image Credit: © Alyona Shu - stock.adobe.com.
Lebrikizumab improves atopic dermatitis symptoms in patients previously on dupilumab

March 7th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.